| This article has been cited by |
| 1 | Musculoskeletal Complications of Fluoroquinolones: Guidelines and Precautions for Usage in the Athletic Population | |
| Mederic M. Hall,Jonathan T. Finnoff,Jay Smith |
| PM&R.2011;3(2)132 |
| [DOI] |
|
| 2 | Moxifloxacin-induced rhabdomyolysis | |
| S. Sanjith,A. Raodeo,A. Clerk,R. Pandit,D. R. Karnad |
| Intensive Care Medicine.2012;38(4)725 |
| [DOI] |
|
| 3 | Levofloxacin-induced rhabdomyolysis in a patient on concurrent atorvastatin: Case report and literature review | |
| Jeannette Bouchard,Nicolas De La Pena,Louise-Marie Oleksiuk |
| Journal of Clinical Pharmacy and Therapeutics.2019;44(6)966 |
| [DOI] |
|
| 4 | Current awareness: Pharmacoepidemiology and drug safety | |
| Jeannette Bouchard,Nicolas De La Pena,Louise-Marie Oleksiuk |
| Pharmacoepidemiology and Drug Safety.2009;18(1)i |
| [DOI] |
|
| 5 | Diplomats' Mystery Illness and Pulsed Radiofrequency/Microwave Radiation | |
| Beatrice Alexandra Golomb |
| Neural Computation.2018;30(11)2882 |
| [DOI] |
|
| 6 | Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis | |
| Andrea J. Grisold,Martin Hoenigl,Thomas Valentin,Ismar Ovcina,Sonja Fruhwald |
| Journal of Infection and Chemotherapy.2013;19(6)1214 |
| [DOI] |
|
| 7 | Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis | |
| Andrea J. Grisold,Martin Hoenigl,Thomas Valentin,Ismar Ovcina,Sonja Fruhwald |
| Journal of Infection and Chemotherapy.2016;19(6)513 |
| [DOI] |
|
| 8 | Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis | |
| Natascia Corti,Alexander Imhof,Christa Wenger |
| Journal of Infection and Chemotherapy.2010;32(6)461 |
| [DOI] |
|
| 9 | Gatifloxacin Ophthalmic Solution for Treatment of Bacterial Conjunctivitis: Safety, Efficacy and Patient Perspective | |
| Clyde Schultz |
| Ophthalmology and Eye Diseases.2012;4(6)OED.S7383 |
| [DOI] |
|
| 10 | Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis | |
| Santiago Vilar,Rave Harpaz,Herbert S Chase,Stefano Costanzi,Raul Rabadan,Carol Friedman |
| Journal of the American Medical Informatics Association.2011;18(Supplement_1)i73 |
| [DOI] |
|
